A low dose immunorestorative effect of aporphinoid alkaloid oxoglaucine on experimentally immunosuppressed and infected mice

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 19, Issue 9, 1997, Pages 579-583

  Ivanovska, Nina ^a   Philipov, Stefan ^b  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

^b INSTITUTE OF ORGANIC CHEMISTRY   (Bulgaria)

Author keywords

Artemisinin; Cyclophosphamide; Delayed type hypersensitivity (DTH); Indomethacin; Klebsiella pneumoniae; Oxoglaucine; Prednisolone

Indexed keywords

APORPHINE DERIVATIVE; ARTEMISININ; CYCLOPHOSPHAMIDE; INDOMETACIN; OXOGLAUCINE; PREDNISOLONE;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; HOST RESISTANCE; IMMUNOREGULATION; INTRAPERITONEAL DRUG ADMINISTRATION; KLEBSIELLA PNEUMONIAE; MALE; MOUSE; NONHUMAN; SURVIVAL TIME;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOMORPHINE; ARTEMISININS; CYCLOPHOSPHAMIDE; DRUG INTERACTIONS; ERYTHROCYTES; HYPERSENSITIVITY, DELAYED; IMMUNOSUPPRESSIVE AGENTS; INDOMETHACIN; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICE; PREDNISOLONE; SESQUITERPENES; SHEEP;

EID: 0031461530     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Lockie, L.M., Norcross, B.M. Saliovlates, phenylbutazone, chloroquines and indomethacin in treatment of rheumatoid arthritis. In: Arthritis and Allied Conditions. Holander, J.L. (Ed.) Lea and Febiger: Philadelphia 1966, 333-48.
2. Bitter, T. Combined disease-modifying chemotherapy for intractable rheumatoid arthritis. Rheum Dis Clin North Am 1984, 10: 413-28.
3. Cegg, D.O. HCQ/MTX study group: Combination hydroxychloroquine and methotrexate in the treatment of rheumatoid arthritis (abstr.). Arthritis Rheum 1993, 36 (Suppl.): 553.
4. Dijkmans, B.A.C., van den Borne, E.E.M., Landewe, R.B.M., Miltenburg, A.M.M., Verweij, C.L., Breedveld, F.C. Chloroquine combined with cysdoaporia in rheumatoid arthritis: More than the addition of 2 drugs alone. J Rhematol 1996, 23 (Suppl. 44): 61-3.
5. Ivanovska, N., Philipov, S., Georgieva, P. Immunopharmacological activity of aporhinoid alkaloid oxoglaucine. Pharmacol Res 1997, 37: 267-72.
6. Bodoy, O.P., Elting, L.S., Rodriguez, S., Hernández, M. Klebsiella bacteremia - a 10 year review in a cancer institution. Cancer 1989, 64: 2368-76.
7. De la Torre, G., Romero-Vivas, J., Martinez-Beltrán, J., Guerrero, A., Meseguer, M., Bouza, E. Klebsiella bacteriemia: An analysis of 100 episodes. Rev Infect Dis 1985, 7: 143-50.
8. Williams, P., Tomás, J.M. The pathogenicity of Klebsiella pneumoniae. Rev Med Microbiol 1990, 1: 196-204.
9. Balow, J.E., Hurley, D.L., Fand, A.S. Cyclophosphamide suppression of established cell-mediated immunity. J Clin Invest 1975, 56: 67-70.
10. Pierson, C.C., Johnson, A.G., Feller, I. Effect of cyclophosphamide on the immune response to Pseudomonas aeruginosa in mice. Infect Immun 1976, 14: 168-77.
11. Miller, T.E., North, K.D. Clinical infections, antibiotics and immunosuppression: A puzzling relationship. Am J Med 1981, 71: 34-6.
12. Vane, J.R., Bolting, R. Inflammation and mechanism of action of antiinflammatory drugs. FASEB J 1987, 1: 89-96.
13. Garber, E.K., Fan, P.T. Bluestone, R. Realistic guidelines of corticosteroid therapy in rheumatic disease. Seminars in Arthr and Rheum 1987, 11: 231-56.
14. Meshnick, S.R., Yang, Y.Z., Lima, V., Kuypers, F., Kamchonwongpaisan, S., Yuthavong, Y. Ion-dependent free radical generation from the antimalarial agent artemisinin (ginghausu). Antimicrob Agents Chemother 1993, 16: 169-80.
15. Woerdenbag, H.J., Pras, W., van Uden, W., Wallaart, T.E., Beekman, A.C., Lugt, C.B. Progress in the research of artemisinin-related antimalarials: An update. Pharm World Sci 1994: 169-80.